Versuchen GOLD - Frei
Premium content production needs to be democratised
Business Standard
|November 22, 2024
Over 13 years, UDAY SHANKAR took Star India from ₹1,600 crore to ₹18,000 crore in revenue when he quit in 2020. He was keen to focus on education and healthcare. But here he is back in media four years later as vice-chairperson of JioStar. The ₹26,000 crore (revenue FY24) firm is India's largest media company. It is the product of the merger between Viacom18 Media and Star India. Viacom18 is owned by Reliance Industries (RIL) and Bodhi Tree Systems, a platform owned equally by Shankar and James Murdoch's Lupa Systems. Star India is a part of The Walt Disney Company. Earlier this week, Vanita Kohli-Khandekar had a chat with Shankar in Mumbai. Edited excerpts:
What are your priorities with JioStar? We deliver the largest share of audiences on TV (110 channels such as Colors and Star Plus, 32 per cent viewership) and digital (Disney+Hotstar and JioCinema offer the second-largest audience after YouTube) every day. There are a lot of things that are working very well and my topmost priority is to not spoil them.
But in a country with 800-850 million mobile customers, if you (the whole streaming business) have 50-70 million subscribers, then there is a whole world to cover over there. Also, streaming content is still designed for a very elite segment. In a country of 1.5 billion people, if several hundred million people are not coming to your platform every night, then there is a problem. I'm not talking about Instagram, YouTube, and Google but the other premium services. It's a huge opportunity that needs creativity and technological innovation.
Finally, there is a narrative that has got built and accepted that TV is dead. It has become self-fulfilling. Every day you say it's dead and you don't feed it. And since you don't feed it, it is going to die.
Diese Geschichte stammt aus der November 22, 2024-Ausgabe von Business Standard.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
